Compare DCOM & PLSE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | DCOM | PLSE |
|---|---|---|
| Founded | 1864 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.4B | 1.2B |
| IPO Year | 1996 | 2016 |
| Metric | DCOM | PLSE |
|---|---|---|
| Price | $30.03 | $14.69 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 3 | 1 |
| Target Price | ★ $34.33 | $22.00 |
| AVG Volume (30 Days) | ★ 270.2K | 202.1K |
| Earning Date | 01-27-2026 | 11-05-2025 |
| Dividend Yield | ★ 3.33% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 1.18 | N/A |
| Revenue | ★ $340,529,000.00 | $86,000.00 |
| Revenue This Year | $47.68 | N/A |
| Revenue Next Year | $22.69 | $1,002.94 |
| P/E Ratio | $25.53 | ★ N/A |
| Revenue Growth | ★ 8.54 | N/A |
| 52 Week Low | $23.25 | $12.56 |
| 52 Week High | $34.00 | $25.00 |
| Indicator | DCOM | PLSE |
|---|---|---|
| Relative Strength Index (RSI) | 45.09 | 49.70 |
| Support Level | $29.04 | $13.17 |
| Resistance Level | $30.38 | $15.65 |
| Average True Range (ATR) | 0.68 | 0.84 |
| MACD | -0.28 | 0.07 |
| Stochastic Oscillator | 20.46 | 42.29 |
Dime Community Bancshares Inc operates as a holding company. It gathers deposits from customers within its market area and via the internet and invests them in multifamily residential, commercial real estate, commercial and industrial (C&I) loans, and one-to-four family residential real estate loans, as well as mortgage-backed securities, obligations of the U.S. government and government- sponsored enterprises (GSEs), and corporate debt and equity securities. The company has one reportable segment which is Community Banking.
Pulse Biosciences Inc is a novel bioelectric medicine company committed to health innovation using its patented Nano-Pulse Stimulation technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. NPS technology, also referred to as Nanosecond Pulsed-Field Ablation or nsPFA technology when used to ablate cellular tissue, can be used to treat a variety of medical conditions for which an optimal solution remains unfulfilled.